FCH
IHE icon

Freestone Capital Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Freestone Capital Holdings’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,359
Closed -$81.3K – 719
2020
Q4 		$81.3K Hold
1,359
– – ﹤0.01% 468
2020
Q3 		$74.1K Buy
+1,359
New +$73.3K ﹤0.01% 432

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Freestone Capital Holdings's IHE Position: Q1 2021 in Review

Freestone Capital Holdings sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2021, closing a stake of 1,359 shares — an estimated $81.3K sold.

Freestone Capital Holdings first reported a position in IHE in Q3 2020 and held it in 2 quarters. The position peaked at $81.3K in Q4 2020. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2021.

  • Freestone Capital Holdings reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 1,359 iShares US Pharmaceuticals ETF shares in Q1 2021, an estimated $81.3K.
  • Freestone Capital Holdings first reported a position in iShares US Pharmaceuticals ETF in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's iShares US Pharmaceuticals ETF position peaked at $81.3K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.